New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
07:04 EDTMAPP
theflyonthewall.com: Map Pharmaceuticals secures $60M committed equity financing facility
MAP Pharmaceuticals has secured a committed equity financing facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity Ltd. MAP Pharmaceuticals is not obligated to utilize any of the $60 million facility, which has a term of 24 months. During the term of the purchase agreement, at its sole discretion and subject to certain conditions, MAP Pharmaceuticals may present Azimuth with draw down notices requiring Azimuth to purchase a specified dollar amount of shares of its common stock at pre-defined terms. Any shares sold under this facility will be registered on MAP Pharmaceuticals' effective shelf registration statement on Form S-3 filed with the Securities and Exchange Commission. :theflyonthewall.com



News For MAPP From The Last 14 Days
Check below for free stories on MAPP the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 2, 2010
11:42 EDTMAPP
theflyonthewall.com: Lazard Capital's Biotech Analyst to host a conference call
Biotech Analyst Tanner hosts two leading migraine specialists who discuss general trends in the treatment of migraines, including Map Pharmaceuticals' Levadex, on an Analyst/Industry conference call to be held on February 3 at 11 am hosted by Lazard Capital. :theflyonthewall.com
08:01 EDTMAPP
theflyonthewall.com: Map Pharmaceuticals target raised to $18 from $13 at Lazard Capital

Subscribe for More Information :theflyonthewall.com

January 28, 2010
06:09 EDTMAPP
theflyonthewall.com: Map Pharma offers 1.53M shares at $13.09 to Azimuth Opportunity Ltd

Subscribe for More Information :theflyonthewall.com